67 results
8-K
EX-99.1
ACXP
Acurx Pharmaceuticals, Inc.
18 Mar 24
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
4:15pm
million increase in professional fees, a $0.1 million increase in share-based compensation, and a $0.3 million increase in employee compensation … of $0.3 million in employee compensation costs.
Net Income/Loss:
The Company reported a net loss of $5.1 million or $0.37 per diluted share
S-8
eiv6elsw1r5
15 Mar 24
Registration of securities for employees
4:33pm
8-K
EX-1.1
rqxdi6
15 Nov 23
Entry into a Material Definitive Agreement
5:02pm
424B5
r4o1v tckdqzw0ouz
15 Nov 23
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.1
c9ot02 sri
14 Aug 23
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2023 Results and Provides Business Update
7:10am
424B3
4say03
13 Jul 23
Prospectus supplement
4:32pm
424B5
v934tmxl4u2
17 May 23
Prospectus supplement for primary offering
4:25pm
8-K
EX-10.1
rtsn20q 4ifd
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm